Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 1, 1993 - Issue 3
10
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Specific Inhibition of Glycosylation by Tunicamycin Affects Endothelin Receptors in Cultured Swiss 3T3 Fibroblasts

&
Pages 153-160 | Received 19 Nov 1992, Accepted 05 Mar 1993, Published online: 13 Jul 2009
 

Abstract

The importance of glycosylation to endothelin (ET) receptors was studied in cultured Swiss 3T3 fibroblasts. ET stimulated phosphatidylinositol hydrolysis by 270% in control cells. This stimulatory effect was decreased to < 130% in tunicamycin (TU)-treated cells. TU inhibited protein glycosylation, but did not effect DNA synthesis, cell morphology, or cell numbers. ET-1 binding was greatly reduced in TU-treated cells. In membranes prepared from control cells, [125]ET-1 binding was saturable, and appeared as a straight line in Scatchard analysis with values of 0.7 pmol/mg and 0.9 nM for Bmax and KD, respectively. [125]ET-1 binding to membranes from TU-treated cells was not saturable. Scatchard analysis showed a biphasic line. Values of Bmax, and KD for the higher affinity site were 0.17 pmol/mg and 0.12 nM, respectively. The low affinity site exhibited a much weaker affinity for ET with an estimated KD value of 6.8 nM. Cross-linking studies revealed that the receptor in control membranes was a protein with a molecular mass of 62 kDa. In membranes from TU-treated cells, two proteins with molecular masses of 62 and 40 kDa were labeled. These data suggest that receptor glycosylation was required for ET binding and the subsequent activation of the phosphatidylinositol hydrolysis pathway.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.